FOXP3 and melanoma: Furthermore, another analysis of 209 advanced melanoma patients showed that baseline levels of low Lin−CD14+HLA−DR−/low-MDSCs and high CD4+CD25+FoxP3+-Tregs, were significantly associated with better survival [69].